Stay updated on Amgen Press Releases

Sign up to get notified when there's something new on the Amgen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Amgen Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The webpage has added significant updates regarding Amgen's upcoming presentations and financial results for the first quarter of 2025.
    Difference
    100%
    Check dated 2025-05-14T21:14:55.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The webpage has removed several significant updates regarding FDA approvals and clinical trial results for various treatments, including UPLIZNA® and LUMAKRAS®, which are crucial for understanding current treatment options and advancements in healthcare.
    Difference
    100%
    Check dated 2025-04-30T13:58:57.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now includes a significant addition regarding the IMDELLTRA® treatment, highlighting its demonstrated superior overall survival in small cell lung cancer as of April 11, 2025.
    Difference
    69%
    Check dated 2025-04-16T05:28:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The webpage now includes significant updates regarding FDA approvals and clinical trial results for various treatments, including UPLIZNA® as the first FDA-approved treatment for IgG4-related disease and new data on its efficacy for generalized myasthenia gravis. Additionally, there are announcements of upcoming presentations and financial results from Amgen.
    Difference
    100%
    Check dated 2025-04-09T01:45:02.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The webpage has been updated with several significant announcements regarding drug approvals, clinical trial results, and upcoming presentations by Amgen, including the approval of LUMAKRAS® for a specific type of cancer and positive results from various clinical trials.
    Difference
    100%
    Check dated 2025-03-25T13:37:08.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The webpage has removed several significant announcements and updates related to Amgen's financial results, product approvals, and conference presentations scheduled for early 2025.
    Difference
    100%
    Check dated 2025-03-18T07:34:52.000Z thumbnail image

Stay in the know with updates to Amgen Press Releases

Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.